Natalie A Little

1.4k citations
7 papers · 1.1k indexed · h-index 7
  • Oncology top 5%
    • Cancer-related Molecular Pathways 6
    • Cancer Research and Treatments 2
    • Epigenetics and DNA Methylation 4
    • RNA modifications and cancer 3
    • Ubiquitin and proteasome pathways 2
    • Renal and related cancers 1
    • Microtubule and mitosis dynamics 1
    • Urological Disorders and Treatments 1

Natalie A Little

7 papers receiving 1.1k citations

Peers

Natalie A Little
Comparison fields: 5 of 64
  • Oncology 851
  • Biotechnology 203
  • Molecular Biology 989
  • Cancer Research 167
  • Cell Biology 95
Replace A Lavigueur with:
A Lavigueur Canada
H W Stürzbecher United Kingdom
JA Pietenpol United States
Adithi Mohan India
Rina Zakut-Houri Israel
So-I Shin Japan
Laurie M. Delmolino United States
Jonathan T. Rhodes United States
Danielle Murphy United States
Y H Xu United States
Natalie A Little relative to A Lavigueur Canada A Lavigueur's profile →
Citations per field
00.5×10×15×20×
A Lavigueur · 1×
Citations per year

Countries citing papers authored by Natalie A Little

Since Specialization
Citations

This map shows the geographic impact of Natalie A Little's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie A Little with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie A Little more than expected).

Fields of papers citing papers by Natalie A Little

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie A Little. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie A Little. The network helps show where Natalie A Little may publish in the future.

Co-authorship network

The 18 scholars most cited alongside Natalie A Little, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Natalie A Little Line = papers co-authored together Natalie A Little links everyone, so they are left out of the graph.

All Works

About Natalie A Little

Natalie A Little is a scholar working on Biotechnology, Oncology and Urology, having authored 7 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (3 papers), Cancer Research and Treatments (2 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (1 paper), Urological Disorders and Treatments (1 paper) and Renal and related cancers (1 paper). The work is most often cited by research in Oncology (851 citations), Biotechnology (203 citations) and Molecular Biology (989 citations). Natalie A Little has collaborated with scholars based in Netherlands, United Kingdom and Mexico. Frequent co-authors include Aart G. Jochemsen, Wen Yan, R. Davies, John M. Parant, Nicholas D. Hastie, V Reinke, Arturo Chávez‐Reyes, Guillermina Lozano, Robert Stad and Alex J. van der Eb. Their work appears in journals such as Journal of Biological Chemistry, Nature Genetics and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026